These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3488762)

  • 1. Characterization of cellular and extracellular plasma membrane vesicles from a low metastatic lymphoma (Eb) and its high metastatic variant (ESb): inhibitory capacity in cell-cell interaction systems.
    Schirrmacher V; Barz D
    Biochim Biophys Acta; 1986 Aug; 860(2):236-42. PubMed ID: 3488762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage.
    Larizza L; Schirrmacher V; Graf L; Pflüger E; Peres-Martinez M; Stöhr M
    Int J Cancer; 1984 Nov; 34(5):699-707. PubMed ID: 6500746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasizing lymphoma (Eb) and its metastasizing variant (ESb).
    Barz D; Goppelt M; Szamel M; Schirrmacher V; Resch K
    Biochim Biophys Acta; 1985 Mar; 814(1):77-84. PubMed ID: 3978101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant.
    Altevogt P; Kurnick JT; Kimura AK; Bosslet K; Schirrmacher V
    Eur J Immunol; 1982 Apr; 12(4):300-7. PubMed ID: 6124426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.
    Vlodavsky I; Fuks Z; Bar-Ner M; Ariav Y; Schirrmacher V
    Cancer Res; 1983 Jun; 43(6):2704-11. PubMed ID: 6601984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic differences between high- and low-metastatic related tumor lines and the problem of tumor progression and variant generation.
    Schirrmacher V; Dzarlieva R; Altevogt P; Fogel M; Waller CA; Dennis JW; Springer GF; Vlodavsky I; Kramer M; Cheingsong-Popov R
    Symp Fundam Cancer Res; 1983; 36():81-99. PubMed ID: 6332358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic changes during tumor progression towards invasion, metastasis and immune escape in the Eb/ESb model system.
    Dzarlieva R; Schirrmacher V; Fusenig NF
    Int J Cancer; 1982 Nov; 30(5):633-42. PubMed ID: 6961115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. X. Immunoselection of tumor variants differing in tumor antigen expression and metastatic capacity.
    Schirrmacher V; Bosslet K
    Int J Cancer; 1980 Jun; 25(6):781-8. PubMed ID: 14768708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
    Altevogt P; Leidig S; Heckl-Oestreicher B
    Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface glycoprotein differences between a highly malignant murine tumor line and a plastic-adherent, less malignant variant.
    Lang E; Altevogt P; Schirrmacher V
    Cancer Detect Prev Suppl; 1987; 1():73-9. PubMed ID: 3480072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines.
    Altevogt P; Fogel M; Cheingsong-Popov R; Dennis J; Robinson P; Schirrmacher V
    Cancer Res; 1983 Nov; 43(11):5138-44. PubMed ID: 6616451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoconjugates of murine tumor lines with different metastatic capacities. I. Differences in fucose utilization and in glycoprotein patterns.
    Schwartz R; Schirrmacher V; Mühlradt PF
    Int J Cancer; 1984 Apr; 33(4):503-9. PubMed ID: 6706434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative differences in position of sialylation and surface expression of glycolipids between murine lymphomas with low metastatic (Eb) and high metastatic (ESb) potentials and isolation of a novel disialoganglioside (GD1 alpha) from Eb cells.
    Murayama K; Levery SB; Schirrmacher V; Hakomori S
    Cancer Res; 1986 Mar; 46(3):1395-402. PubMed ID: 3484680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and enhanced secretion of proteochondroitin sulphate in a metastatic variant of a mouse lymphoma cell line.
    Schwartz-Albiez R; Steffen I; Lison A; Güttler N; Schirrmacher V; Keller R
    Br J Cancer; 1988 Jun; 57(6):569-75. PubMed ID: 3408644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
    Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
    Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance.
    Vlodavsky I; Schirrmacher V; Ariav Y; Fuks Z
    Invasion Metastasis; 1983; 3(2):81-97. PubMed ID: 6677623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation.
    Fogel M; Altevogt P; Schirrmacher V
    J Exp Med; 1983 Jan; 157(1):371-6. PubMed ID: 6848622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VIII. Expression and shedding of Fc gamma receptors on metastatic tumor cell variants.
    Schirrmacher V; Jacobs W
    J Supramol Struct; 1979; 11(1):105-11. PubMed ID: 522481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of high or low metastatic related tumor lines with normal or lymphokine-activated syngeneic peritoneal macrophages: in vitro analysis of tumor cell binding and cytostasis.
    Schirrmacher V; Appelhans B
    Clin Exp Metastasis; 1985; 3(1):29-43. PubMed ID: 4042455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for altered soybean agglutinin lectin binding between a murine metastatic lymphoma and an adhesive low malignant variant.
    Lang E; Kohl U; Schirrmacher V; Brossmer R; Altevogt P
    Exp Cell Res; 1987 Nov; 173(1):232-43. PubMed ID: 2445594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.